|
Corporate Social Responsibility
News
12.08.2005 ET
|
CSR News from:
|
|
|
News Category:
|
|
Novartis Employees Honored with Energy Excellence Awards
(CSRwire) Basel, Switzerland - Five Novartis project team leaders from sites
in Bangladesh, India, Ireland and the US were honored today with the
Energy Excellence Awards for their exceptional contributions to improving
energy efficiency and reducing carbon dioxide (CO2) emissions throughout
the company.
"Energy efficiency has long been a key objective at Novartis, and we are
proud to see that our employees are committed to this goal," said Dr. Urs
Bärlocher, Head of Legal and General Affairs and a member of the Novartis
Executive Committee, at an award ceremony in Basel.
Launched in 2004, the Novartis Energy Excellence Awards recognize
achievements in energy management and encompass all business processes -
from production and logistics to facility management and administration.
These contributions support the voluntary commitment of Novartis to reduce
global direct greenhouse gas emissions of CO2 to 5% below the 1990 level in
accordance with the Kyoto Protocol (2008-2012 period).
The 2005 awards were given in three categories:
Efficiency for projects demonstrating outstanding energy efficiency or
financial return
Technology for projects deploying new technology, renewable or
alternative energy use for environmental improvement
Cultural change for projects stimulating change in employee
behavior
A total of 37 projects were submitted from all divisions and business
units within Novartis. Five projects were rewarded and eight received a
special recognition from the panel. The panel included representatives
from Novartis as well as experts from the Basel Agency for Sustainable
Energy (BASE), Novatlantis of ETH Zurich , and the World Business Council
for Sustainable Development (WBCSD).
About Novartis
Novartis AG (NYSE: NVS) is a world leader in pharmaceuticals and consumer
health. In 2004, the Novartis Group's businesses achieved sales of USD
28.2 billion and pro forma net income of USD 5.6 billion. The Group
invested approximately USD 4.1 billion in R&D. Headquartered in Basel,
Switzerland, Novartis Group companies employ about 91,700 people and
operate in over 140 countries around the world. For further information
please consult http://www.novartis.com
|
|
